These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 2033400)

  • 1. Preservation of the C-terminus of dystrophin molecule in the skeletal muscle from Becker muscular dystrophy.
    Arahata K; Beggs AH; Honda H; Ito S; Ishiura S; Tsukahara T; Ishiguro T; Eguchi C; Orimo S; Arikawa E
    J Neurol Sci; 1991 Feb; 101(2):148-56. PubMed ID: 2033400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy.
    Winnard AV; Klein CJ; Coovert DD; Prior T; Papp A; Snyder P; Bulman DE; Ray PN; McAndrew P; King W
    Hum Mol Genet; 1993 Jun; 2(6):737-44. PubMed ID: 8353493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunofluorescence dystrophin study in Duchenne dystrophy through the concomitant use of two antibodies directed against the carboxy-terminal and the amino-terminal region of the protein.
    Vainzof M; Zubrzycka-Gaarn EE; Rapaport D; Passos-Bueno MR; Pavanello RC; Pavanello-Filho I; Zatz M
    J Neurol Sci; 1991 Feb; 101(2):141-7. PubMed ID: 1709683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion.
    Koenig M; Beggs AH; Moyer M; Scherpf S; Heindrich K; Bettecken T; Meng G; Müller CR; Lindlöf M; Kaariainen H; de la Chapellet A; Kiuru A; Savontaus ML; Gilgenkrantz H; Récan D; Chelly J; Kaplan JC; Covone AE; Archidiacono N; Romeo G; Liechti-Gailati S; Schneider V; Braga S; Moser H; Darras BT; Murphy P; Francke U; Chen JD; Morgan G; Denton M; Greenberg CR; Wrogemann K; Blonden LA; van Paassen MB; van Ommen GJ; Kunkel LM
    Am J Hum Genet; 1989 Oct; 45(4):498-506. PubMed ID: 2491009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of a dystrophin gene deletion by amplification of mRNA isolated from DMD myotubes cultured in vitro.
    Ehrenpreis J; Hillers M; Junkes B; Pfordt M; Schwinger E; Vosberg HP
    Genomics; 1991 Jul; 10(3):551-7. PubMed ID: 1889805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is dystrophin labelling always discontinuous in Becker muscular dystrophy?
    Slater CR; Nicholson LV
    J Neurol Sci; 1991 Feb; 101(2):187-92. PubMed ID: 2033404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dystrophin or a "related protein" in Duchenne muscular dystrophy?
    Nicholson LV; Johnson MA; Davison K; O'Donnell E; Falkous G; Barron M; Harris JB
    Acta Neurol Scand; 1992 Jul; 86(1):8-14. PubMed ID: 1519480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular pathology of Duchenne and Becker muscular dystrophy].
    Gilgenkrantz H; Chelly J; Récan D; Chafey P; Kaplan JC
    C R Seances Soc Biol Fil; 1992; 186(4):349-53. PubMed ID: 1301222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Very mild muscular dystrophy associated with the deletion of 46% of dystrophin.
    England SB; Nicholson LV; Johnson MA; Forrest SM; Love DR; Zubrzycka-Gaarn EE; Bulman DE; Harris JB; Davies KE
    Nature; 1990 Jan; 343(6254):180-2. PubMed ID: 2404210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the maintainance of the C-terminus domain of dystrophin enough to ensure a milder Becker muscular dystrophy phenotype?
    Vainzof M; Takata RI; Passos-Bueno MR; Pavanello RC; Zatz M
    Hum Mol Genet; 1993 Jan; 2(1):39-42. PubMed ID: 8490621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies against the muscle-specific N-terminus of dystrophin: characterization of dystrophin in a muscular dystrophy patient with a frameshift deletion of exons 3-7.
    Le TT; Nguyen TM; Love DR; Helliwell TR; Davies KE; Morris GE
    Am J Hum Genet; 1993 Jul; 53(1):131-9. PubMed ID: 8317478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcolemmal expression of dystrophin C-terminus but reduced expression of 6q-dystrophin-related protein in two DMD patients with large deletions of the dystrophin gene.
    Bittner RE; Shorny S; Ferlings R; Sperl W; Kress W; Müller CR; Cremer M; Léger JJ; Voit T
    Neuromuscul Disord; 1995 Mar; 5(2):81-92. PubMed ID: 7767097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frameshift deletions of exons 3-7 and revertant fibers in Duchenne muscular dystrophy: mechanisms of dystrophin production.
    Winnard AV; Mendell JR; Prior TW; Florence J; Burghes AH
    Am J Hum Genet; 1995 Jan; 56(1):158-66. PubMed ID: 7825572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A homologue of dystrophin is expressed at the blood vessel membrane of DMD and BMD patients: immunological evidence.
    Augier N; Boucraut J; Léger J; Anoal M; Nicholson LV; Voelkel MA; Léger JJ; Pellissier JF
    J Neurol Sci; 1992 Feb; 107(2):233-8. PubMed ID: 1564523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dystrophin as a diagnostic marker in Duchenne and Becker muscular dystrophy. Correlation of immunofluorescence and western blot.
    Voit T; Stuettgen P; Cremer M; Goebel HH
    Neuropediatrics; 1991 Aug; 22(3):152-62. PubMed ID: 1944822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unraveling the mysteries of Duchenne and Becker muscular dystrophy.
    Hyser CL
    Mol Chem Neuropathol; 1989 Feb; 10(1):15-20. PubMed ID: 2660836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of Duchenne and Becker muscular dystrophy phenotypes with amino- and carboxy-terminal antisera specific for dystrophin.
    Bulman DE; Murphy EG; Zubrzycka-Gaarn EE; Worton RG; Ray PN
    Am J Hum Genet; 1991 Feb; 48(2):295-304. PubMed ID: 1990838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunostaining of dystrophin and utrophin in skeletal muscle of dystrophinopathies.
    Sahashi K; Ibi T; Suoh H; Nakao N; Tashiro M; Marui K; Arahata K; Sugita H
    Intern Med; 1994 May; 33(5):277-83. PubMed ID: 7949630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of epitope libraries to identify exon-specific monoclonal antibodies for characterization of altered dystrophins in muscular dystrophy.
    Nguyen TM; Morris GE
    Am J Hum Genet; 1993 Jun; 52(6):1057-66. PubMed ID: 7684887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The "rescue" of dystrophin synthesis in boys with Duchenne muscular dystrophy.
    Nicholson LV
    Neuromuscul Disord; 1993; 3(5-6):525-31. PubMed ID: 8186705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.